Cargando…

Pathogenesis and New Therapeutic Targets of Ovarian Cancer

Detalles Bibliográficos
Autores principales:	Shih, Ie-Ming, Ho, Chih-Ming, Nakayama, Kentaro, Salani, Ritu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437294/ https://www.ncbi.nlm.nih.gov/pubmed/22969800 http://dx.doi.org/10.1155/2012/867512

Ejemplares similares

Amplification of The ch19p13.2 NACC1 Locus in Ovarian High-grade Serous Carcinoma
por: Shih, Ie-Ming, et al.
Publicado: (2011)

BRCA mutation in ovarian cancer: testing, implications and treatment considerations
por: Neff, Robert T., et al.
Publicado: (2017)

New Insights into Diabetic Kidney Disease: The Potential Pathogenesis and Therapeutic Targets
por: Liu, Wei Jing, et al.
Publicado: (2017)

Multiomic characterization of high-grade serous ovarian carcinoma: editorial commentary on recent application and consideration for future directions
por: Jones, Tiffany Nicole, et al.
Publicado: (2023)

Research of Pathogenesis and Novel Therapeutics in Arthritis
por: Tang, Chih-Hsin
Publicado: (2019)

NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway
por: Jinawath, Natini, et al.
Publicado: (2009)

Research of Pathogenesis and Novel Therapeutics in Arthritis 2.0
por: Tang, Chih-Hsin
Publicado: (2020)

Research of Pathogenesis and Novel Therapeutics in Arthritis 3.0
por: Tang, Chih-Hsin
Publicado: (2023)

Rheumatic Diseases: New Progress in Clinical Research and Pathogenesis
por: Koo, Malcolm, et al.
Publicado: (2023)

Follicular fluid has more to offer: Insulin-like growth factor axis on ovarian carcinogenesis
por: Chu, Tiffany, et al.
Publicado: (2019)

Endometriosis: benign, malignant, or something in between?
por: Chui, M. Herman, et al.
Publicado: (2017)

Targeting Inflammation in Ovarian Cancer Through Natural Antioxidants, Potential Therapeutic and Preventive Implications
por: Singh, Mayank, et al.
Publicado: (2018)

MicroRNA Expression and Identification of Putative miRNA Targets in Ovarian Cancer
por: Dahiya, Neetu, et al.
Publicado: (2008)

New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of Pediatric Medulloblastoma
por: Fang, Francia Y., et al.
Publicado: (2022)

Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases
por: Wang, Jing-Hua
Publicado: (2023)

The Role of Forkhead Box Q1 Transcription Factor in Ovarian Epithelial Carcinomas
por: Gao, Min, et al.
Publicado: (2012)

Pathogenesis and Potential Therapeutic Targets for Triple-Negative Breast Cancer
por: Li, Chia-Jung, et al.
Publicado: (2021)

DNA Damage Response is Prominent in Ovarian High-Grade Serous Carcinomas, Especially Those with Rsf-1 (HBXAP) Overexpression
por: Kshirsagar, Malti, et al.
Publicado: (2012)

Rheumatoid Arthritis from Pathogenesis to Therapeutic Strategies
por: Mueller, Ruediger B., et al.
Publicado: (2020)

The Pathogenesis of COVID-19 Indicates Therapeutic Strategies
por: Li, Tai-Sheng, et al.
Publicado: (2021)

Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics
por: Timchenko, Lubov
Publicado: (2022)

Pathogenesis and Targeted Therapy of Epilepsy
por: N’Gouemo, Prosper
Publicado: (2022)

New molecular aspects in pathogenesis and progression of pancreatic cancer
por: Büchler, Peter, et al.
Publicado: (2003)

MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities
por: Chen, San-Nung, et al.
Publicado: (2019)

Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms
por: Cobb, Lauren Patterson, et al.
Publicado: (2015)

Mechanisms and Novel Therapeutic Approaches for Gynecologic Cancer
por: Nakayama, Naomi
Publicado: (2022)

Advancing Cancer Research: Insights and Innovations in Pathogenesis and Targeted Therapies
por: Wu, Yong, et al.
Publicado: (2023)

New Cytokines in the Pathogenesis of Atopic Dermatitis—New Therapeutic Targets
por: Klonowska, Jolanta, et al.
Publicado: (2018)

New Insights into Bacterial Pathogenesis
por: Biondo, Carmelo
Publicado: (2022)

Oxidative Stress in Metabolic Disorders: Pathogenesis, Prevention, and Therapeutics
por: Yadav, Umesh C. S., et al.
Publicado: (2016)

Oxidative Stress in Liver Diseases: Pathogenesis, Prevention, and Therapeutics
por: Jadeja, Ravirajsinh N., et al.
Publicado: (2017)

Editorial to the Special Issue “Pathogenesis and Novel Therapeutics in Asthma”
por: Bazan-Socha, Stanisława, et al.
Publicado: (2023)

Epithelial Ovarian Cancer: Focus on Targeted Therapy
por: Markman, M., et al.
Publicado: (2010)

Special Issue: The Role of Gut Microbiota in Gastrointestinal Cancers—From Pathogenesis to Therapeutic Perspectives
por: Niikura, Ryota
Publicado: (2023)

New Therapeutic Target for Pulmonary Arterial Hypertension
por: Yoon, Kyung Lim
Publicado: (2018)

Therapeutic targets and new directions for antibodies developed for ovarian cancer
por: Bax, Heather J., et al.
Publicado: (2016)

Alternative Splicing: A New Therapeutic Target for Ovarian Cancer
por: Yao, Shijie, et al.
Publicado: (2022)

Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer
por: Lee, Yu-Chieh, et al.
Publicado: (2015)

Novel Therapeutic Targets in Cancers
por: Levantini, Elena
Publicado: (2023)

New insights in understanding the pathogenesis of spondyloarthropathies
por: van der Horst-Bruinsma, Irene E, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2qn0pu7dil2nd8lpckeo057gc6